IPO
Rznomics Inc.
알지노믹스
Stock page →What the company does
The company develops RNA-based therapeutics using its RNA trans-splicing ribozyme platform technology for genetic disease and cancer candidates. It seeks to generate drug candidates through licensing and development.
Themes:Biotech (new drugs)
- Market
- KOSDAQ
- Price range
- ₩17,000 – ₩22,500
- Offer price
- ₩22,500
- Subscription
- Not set yet
- Payment date
- Not set yet
- Listing
- Dec 18, 2025
- First day
- ▲ +300.0% ₩90,000
- First close vs the offer price
Filings
- [기재정정]투자설명서Dec 5, 2025Open on DART ↗
- [발행조건확정]증권신고서(지분증권)Dec 5, 2025Open on DART ↗
- 투자설명서Dec 3, 2025Open on DART ↗
- [첨부정정]증권신고서(지분증권)Nov 14, 2025Open on DART ↗
- [기재정정]증권신고서(지분증권)Nov 14, 2025Open on DART ↗
- [기재정정]증권신고서(지분증권)Nov 11, 2025Open on DART ↗
- [기재정정]증권신고서(지분증권)Oct 29, 2025Open on DART ↗
- [기재정정]증권신고서(지분증권)Oct 28, 2025Open on DART ↗
How a Korean IPO works: institutions bid first (the demand forecast), which sets the final offer price; then individuals subscribe for two days through the lead managers' brokerage accounts; shares start trading on the listing date.
Dates and prices can change until the final terms are filed. Not financial advice. · Updated Oct 17, 2026 · IPO calendar